• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Discovery Laboratories Inc

+ Add to Watchlist


0.921 EUR 0.068 6.88%

As of 15:17:44 ET on 12/23/2014.

Snapshot for Discovery Laboratories Inc (DYBN)

Open: 0.987 Day's Range: 0.913 - 1.025 Volume: 3,750
Previous Close: 0.989 52wk Range: 0.843 - 1.957 1-Yr Rtn: -43.22%

Stock Chart for DYBN

No chart data available.
  • DYBN:GR 0.975
  • 1D
  • 1M
  • 1Y
Interactive DYBN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DYBN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -0.4091
Est. EPS (USD) (12/2014) -0.5350
Est. PEG Ratio -
Market Cap (M EUR) 78.60
Shares Outstanding (M) 85.34
30 Day Average Volume 298
Price/Book (mrq) 3.4268
Price/Sale (ttm) 61.2058
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DYBN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DYBN

Discovery Laboratories, Inc. is a biopharmaceutical company that develops its proprietary surfactant technology as Surfactant Replacement Therapies (SRT) for respiratory diseases. Through this technology, pulmonary surfactants have the potential to be developed into a series of respiratory therapies for patients in the neonatal care unit, critical care unit and other hospital settings.

John G CooperPresident/CEOJohn A TattorySenior VP/CFO
Steven G SimonsonSenior VP/Chief Dev OfcrThomas F MillerSenior VP/COO
More Company Profile & Key Executives for DYBN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil